Dr. Kareem A Zaghloul, M.D.
Claim this profileClinical Trials Kareem A Zaghloul, M.D. is currently running
More about Kareem A Zaghloul, M.D.
Clinical Trial Related
14 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Kareem A Zaghloul, M.D. has experience with
- Deep Brain Stimulation
Breakdown of trials Kareem A Zaghloul, M.D. has run
Parkinson's Disease
Functional Movement Disorder
Essential Tremor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kareem A Zaghloul, M.D. specialize in?
Kareem A Zaghloul, M.D. focuses on Dystonia and Parkinson's Disease. In particular, much of their work with Dystonia has involved treating patients, or patients who are undergoing treatment.
Is Kareem A Zaghloul, M.D. currently recruiting for clinical trials?
Yes, Kareem A Zaghloul, M.D. is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Kareem A Zaghloul, M.D. has studied deeply?
Yes, Kareem A Zaghloul, M.D. has studied treatments such as Deep Brain Stimulation.
What is the best way to schedule an appointment with Kareem A Zaghloul, M.D.?
Apply for one of the trials that Kareem A Zaghloul, M.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.